HUM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03
Prezzo $388.36
Capitalizzazione di Mercato (MRQ) $77.17B
P/E (TTM) 36.7
EPS (TTM) $10.59
Ricavi (TTM) $145.68B
Rendimento div. 0.55%
ROE (TTM) 6.8%
D/E Debito/Patrimonio (MRQ) 0.6
Intervallo 52 sett. $163–$429

HUM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04
intervallo
barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 4
Data ex-dividendo Split Tipo
01 Agosto 1991 3-for-2 Avanti
01 Febbraio 1984 6-for-5 Avanti
01 Febbraio 1983 4-for-3 Avanti
01 Febbraio 1982 3-for-2 Avanti

Informazioni su Humana Inc. Common Stock Panoramica della società da Wikipedia

05 · wikidata

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.

In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.

In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.

In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.

In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti67.060 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06
Ricavi$129.66B
2016-12-31 → 2025-12-31
EPS$9.84
2016-12-31 → 2025-12-31
Flusso di cassa libero$375M
2016-12-31 → 2025-12-31
Margine netto0.88%
2016-12-31 → 2025-12-31
Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica Tendenza 5 anni HUM media 5 anni Mediana dei peer Verdetto
P/E (TTM) 36.7media 5 anni ≈23.6 ≈23.6 36.3 Sopravvalutato
P/S (TTM) 0.5media 5 anni ≈0.7 ≈0.7 0.7 Sottovalutato
P/B (MRQ) 4.0media 5 anni ≈4.6 ≈4.6 3.9 Valore equo
EV / EBITDA 25.8media 5 anni ≈19.0 ≈19.0 16.1 Valore equo
Prezzo / FCF (TTM) 39.6media 5 anni ≈54.2 ≈54.2 · ·
Prezzo / Flusso di cassa (TTM) 30.4media 5 anni ≈29.3 ≈29.3 15.6 Sopravvalutato
EV / Ricavi (TTM) 0.4media 5 anni ≈0.6 ≈0.6 · ·
EV / FCF (TTM) 33.5media 5 anni ≈46.5 ≈46.5 · ·
Prezzo / Valore contabile tangibile (MRQ) 4.3media 5 anni ≈14.5 ≈14.5 · ·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

13
Dividend Yield0.55%
Rapporto di Distribuzione Utili36.2%
Pagamento annualizzato≈$3.54Pagato trimestralmente
CAGR Dividendi 5Y≈7.2%Per azione, rettificato per lo split
Data ex-dividendoImportoValutaRendimento
Giu 26, 2026$0,89USD≈0.92%
Mar 27, 2026$0,89USD≈2.1%
Dic 26, 2025$0,89USD≈1.4%
Set 26, 2025$0,89USD≈1.4%
Giu 27, 2025$0,89USD≈1.5%
Mar 28, 2025$0,89USD≈1.3%
Dic 31, 2024$0,89USD≈1.4%
Set 30, 2024$0,89USD≈1.1%
Giu 28, 2024$0,89USD≈0.95%
Mar 27, 2024$0,89USD≈1.0%
Dic 28, 2023$0,89USD≈0.78%
Set 28, 2023$0,89USD≈0.70%
Giu 29, 2023$0,89USD≈0.75%
Mar 30, 2023$0,89USD≈0.67%
Dic 29, 2022$0,79USD≈0.61%
Set 29, 2022$0,79USD≈0.62%
Giu 29, 2022$0,79USD≈0.64%
Mar 30, 2022$0,79USD≈0.66%
Dic 30, 2021$0,70USD≈0.60%
Set 29, 2021$0,70USD≈0.69%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14
Sorpresa media 6.5%
Prossimo report Nov 06, 2026
PeriodoRapportoEPS ActualEPS StimatoSorpresa
30 Giugno 2026 Lug 29, 2026 $7.61 $7.29 4.3%
31 Marzo 2026 $10.31 $10.29 0.21%
31 Dicembre 2025 $-3.96 $-4.05 2.1%
30 Settembre 2025 $3.24 $2.85 13.8%
30 Giugno 2025 $6.27 $5.98 4.9%
31 Marzo 2025 $11.58 $10.17 13.9%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15
Conto Economico 13
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue $129.66B$117.76B$106.37B$92.87B$83.06B$77.16B$64.89B$56.91B$53.77B$54.38B$54.29B$48.50B
SG&A Expense $15.45B$13.70B$13.19B$12.67B$10.12B$10.05B$7.38B$7.53B$6.57B$7.17B$7.29B$7.64B
Operating Income $2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B$2.35B$2.36B
Interest Expense ··$493M$401M$326M$283M$242M$218M$242M$189M$186M$192M
Other Non-op $-451M$-181M$-137M$-68M$532M$-103M$506M$-33M$0$0··
Pretax Income $1.44B$1.62B$3.33B$3.57B$3.42B$4.67B$3.47B$2.07B$4.02B$1.55B$2.43B$2.17B
Income Tax $250M$413M$836M$762M$485M$1.31B$763M$391M$1.57B$938M$1.16B$1.02B
Net Income $1.19B$1.21B$2.49B$2.81B$2.93B$3.37B$2.71B$1.68B$2.45B$614M$1.28B$1.15B
EPS (Basic) $9.87$10.01$20.09$22.20$22.79$25.47$20.20$12.24$16.94$4.11$8.54$7.44
EPS (Diluted) $9.84$9.98$20.00$22.08$22.67$25.31$20.10$12.16$16.81$4.07$8.44$7.36
Shares (Basic) 120,454,000120,571,000123,866,000126,419,000128,688,000132,199,000134,055,000137,486,000144,493,000149,375,000149,455,000154,187,000
Shares (Diluted) 120,826,000120,869,000124,441,000127,094,000129,396,000133,012,000134,727,000138,403,000145,585,000150,917,000151,142,000155,874,000
EBITDA $2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B$2.35B$2.36B
Stato Patrimoniale 26
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents $4.20B$2.22B$4.69B$5.06B$3.39B$4.67B$4.05B$2.34B$4.04B$3.88B$2.57B$1.94B
Short-term Investments $15.70B$18.21B$16.63B$13.88B$13.19B$12.55B$10.97B·····
Receivables $3.27B$2.70B$2.04B$1.67B$1.81B$1.14B$1.06B$1.01B$854M$1.28B$1.16B$1.05B
Other Current Assets $9.56B$6.68B$6.63B$5.57B$6.49B$5.28B$3.81B$3.56B$2.95B$3.44B$4.71B$4.01B
Current Assets $32.73B$29.82B$29.99B$26.18B$24.89B$23.64B$19.89B$16.95B$17.40B$16.19B$15.71B$15.54B
PP&E (Net) $2.23B$2.53B$3.03B$3.22B$3.07B$2.37B$1.96B$1.74B$1.58B$1.50B$1.38B$1.23B
PP&E (Gross) $5.52B$5.67B$5.88B$6.36B$5.95B$5.49B$4.62B$4.05B$3.56B$3.19B$2.72B$2.91B
Accum. Depreciation $3.29B$3.14B$2.85B$3.14B$2.87B$3.12B$2.66B$2.31B$1.98B$1.69B$1.34B$1.68B
Goodwill $9.69B$9.63B$9.55B$9.14B$11.09B$4.45B$3.93B$3.90B$3.28B$3.27B$3.27B$3.23B
Intangibles $1.13B$1.44B$1.69B$1.76B$2.64B$329M$177M$245M$226M$280M$357M$440M
Other Non-current Assets $3.13B$3.38B$3.38B$3.38B$4.38B$2.13B$1.83B$1.38B$2.17B$2.23B$2.48B$1.58B
Total Assets $48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B$24.68B$23.53B
Accounts Payable $5.72B$5.26B$6.57B$5.24B$4.51B$4.01B$3.75B$3.07B$4.07B$2.47B$2.21B$2.10B
Short-term Debt ·······$1.69B$150M$300M$299M$0
Current Liabilities $16.35B$16.94B$18.87B$17.18B$15.33B$13.39B$10.93B$10.08B$9.41B$7.82B$8.15B$7.47B
Capital Leases $418M$392M$444M$456M$546M$355M$332M·····
Other Non-current Liabilities $2.46B$1.95B$1.66B$1.47B$2.38B$1.79B$1.14B$581M$237M$263M$235M$236M
Total Liabilities $31.17B$30.03B$30.75B$27.68B$28.25B$21.24B$17.04B$15.25B$17.34B$14.71B$14.33B$13.88B
Total Debt $12.37B$11.14B$10.21B$9.03B$10.54B$6.06B$4.97B$6.07B$4.92B$4.09B$4.12B$3.83B
Common Stock $33M$33M$33M$33M$33M$33M$33M$33M$33M$33M$33M$33M
Retained Earnings $29.07B$28.32B$27.54B$25.49B$23.09B$20.52B$17.48B$15.07B$13.67B$11.45B$11.02B$9.92B
Treasury Stock $14.42B$14.37B$13.66B$12.16B$10.16B$9.92B$8.46B$7.32B$6.33B$3.30B$3.29B$2.86B
AOCI $-633M$-1.07B$-999M$-1.30B$42M$391M$156M$-159M$19M$-66M$58M$223M
Stockholders' Equity $17.66B$16.38B$16.26B$15.31B$16.08B$13.73B$12.04B$10.16B$9.84B$10.69B$10.35B$9.65B
Liabilities + Equity $48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B$24.68B$23.53B
Shares Outstanding 198,719,000198,719,000198,690,000198,667,000198,649,000198,649,000198,630,000·····
Flusso di cassa 17
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A $698M$839M$779M$709M$596M··$444M$410M$388M$354M$328M
Stock-based Comp $241M$207M$175M$216M$180M$181M$163M$137M$157M$115M$109M$98M
Deferred Tax $75M$-192M$-164M$-100M$15M$195M$162M$194M$132M$-71M$-2M$-64M
Amort. of Intangibles $51M$60M$67M$81M$65M$88M$70M$90M$75M$77M$93M$121M
Restructuring ······$47M·$148M···
Operating Cash Flow $921M$2.97B$3.98B$4.59B$2.26B$5.64B$5.28B$2.17B$4.05B$1.94B$868M$1.62B
CapEx $546M$575M$1.00B$1.14B$1.34B$964M$736M$612M$524M$527M$523M$528M
Investing Cash Flow $2.27B$-2.95B$-3.49B$-1.01B$-6.56B$-3.06B$-1.28B$-3.09B$-2.94B$-1.36B$320M$-63M
Net Debt Issued ······$-400M$0$-800M$0$0$-500M
Stock Repurchased $151M$817M$1.57B$2.10B$79M$1.82B$1.07B$1.09B$3.37B$104M$385M$872M
Net Stock Activity $-151M$-817M$-1.57B$-2.10B$-79M$-1.82B$-1.07B$-1.09B$-3.37B$-104M$-385M$-872M
Dividends Paid $430M$431M$431M$392M$354M$323M$291M$265M$220M$177M$172M$172M
Financing Cash Flow $-1.22B$-2.49B$-856M$-1.91B$3.02B$-1.96B$-2.29B$-785M$-945M$732M$-552M$-758M
Net Change in Cash $1.98B$-2.47B$-367M$1.67B$-1.28B$619M$1.71B$-1.70B$165M$1.31B$636M$797M
Taxes Paid ·$570M$997M$758M$227M$1.13B$518M$631M$1.50B$916M$1.18B$1.03B
Free Cash Flow $375M$2.39B$2.98B$3.47B$946M$4.67B$4.55B$1.56B$3.52B$1.41B$345M$1.09B
Levered FCF ··$2.61B$3.15B$666M$4.47B$4.36B$1.38B$3.38B$1.33B$247M$989M
Redditività 7
Metrica Tendenza 202520242023202220212020201920182017201620152014
Operating Margin 2.1%2.2%3.8%4.1%3.8%6.5%4.9%5.5%7.9%3.2%4.3%4.9%
Net Margin 0.92%1.0%2.3%3.0%3.5%4.4%4.2%3.0%4.5%1.1%2.4%2.4%
Pretax Margin 1.1%1.5%3.1%3.8%4.1%6.1%5.3%3.6%7.5%2.9%4.5%4.5%
EBITDA Margin 2.1%2.2%3.8%4.1%3.8%6.5%4.9%5.5%7.9%3.2%4.3%4.9%
ROA 2.5%2.6%5.5%6.4%7.4%10.5%9.9%6.4%9.3%2.5%5.3%5.2%
ROE 7.0%7.4%15.8%18.2%18.1%22.8%22.9%16.2%23.3%5.8%12.8%12.1%
ROIC 7.4%7.1%11.3%12.3%10.1%18.1%14.6%15.5%17.6%4.7%8.5%9.3%
Liquidità e Solvibilità 5
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 2.01.81.61.51.61.81.81.71.92.11.92.0
Quick Ratio 1.41.41.21.21.21.40.50.30.50.70.50.4
Debt / Equity 0.70.70.60.60.70.40.40.60.50.40.40.4
LT Debt / Equity 0.70.70.60.60.70.40.40.40.50.40.40.4
Interest Coverage ··8.19.59.717.613.214.217.69.212.612.3
Efficienza 2
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 2.72.52.42.12.12.42.42.22.02.22.32.2
Receivables Turnover 43.449.757.453.356.370.362.760.950.444.649.045.8
Per Azione 7
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share $88.85$82.40$81.85$77.07········
Revenue / Share $1073.15$974.29$854.81$730.72$641.94$580.06$481.63$411.20$369.32$360.32$359.19$311.15
Cash Flow / Share $7.62$24.54$31.99$36.09$17.48$42.39$39.22$15.70$27.83$12.83$5.74$10.38
Cash / Share $21.14$11.18$23.62$25.47········
Dividend / Share ·········$1.16$1.15$1.11
Dividend Paid / Share $3.54$3.54$3.44$3.06$2.73$2.43$2.15$1.90$1.49$1.16$1.14$1.10
EPS (TTM) $9.84$9.98$20.00$22.08$22.67$25.31$20.10$12.16$16.81$4.07$8.44$7.36
Tassi di Crescita 10
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 10.1%10.7%14.5%11.8%7.7%·······
Revenue CAGR 3Y 11.8%12.3%11.3%·········
Revenue CAGR 5Y 10.9%···········
EPS YoY -1.4%-50.1%-9.4%-2.6%-10.4%·······
EPS CAGR 3Y -23.6%-23.9%-7.5%·········
EPS CAGR 5Y -17.2%···········
Net Income YoY -1.6%-51.5%-11.3%-4.3%-12.9%·······
Net Income CAGR 3Y -24.9%-25.6%-9.6%·········
Net Income CAGR 5Y -18.8%···········
Dividends Paid CAGR 5Y 5.9%···········
Valutazione (TTM) 17
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM $129.66B$117.76B$106.37B$92.87B$83.06B$77.16B$64.89B$56.91B$53.77B$54.38B$54.29B$48.50B
Net Income TTM $1.19B$1.21B$2.49B$2.81B$2.93B$3.37B$2.71B$1.68B$2.45B$614M$1.28B$1.15B
Market Cap $50.90B$50.42B$90.96B$101.76B········
Enterprise Value $43.36B$41.13B$79.86B$91.85B········
P/E 26.025.422.923.220.516.218.223.614.850.121.219.5
P/S 0.40.40.91.1········
P/B 2.93.15.66.6········
P / Tangible Book 7.49.518.123.1········
P / Cash Flow 55.317.022.822.2········
P / FCF 135.721.130.629.3········
EV / EBITDA 16.016.119.924.2········
EV / FCF 115.617.226.826.5········
EV / Revenue 0.30.30.81.0········
Dividend Yield 0.84%0.85%0.47%0.39%········
Earnings Yield 3.8%3.9%4.4%4.3%4.9%6.2%5.5%4.2%6.8%2.0%4.7%5.1%
Payout Ratio 36.2%35.7%17.3%14.0%12.1%9.6%10.8%15.8%9.0%28.8%13.5%15.0%
Annual Payout $430M$431M$431M$392M$354M$323M$291M$265M$220M$177M$172M$172M

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16
Metrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $129.66B $117.76B $106.37B $92.87B $83.06B
Margine Operativo % 2.1% 2.2% 3.8% 4.1% 3.8%
Utile netto $1.19B $1.21B $2.49B $2.81B $2.93B
EPS Diluito $9.84 $9.98 $20.00 $22.08 $22.67

Proprietari istituzionali (13F) 1.038 filer · $52.7B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 1.038
Valore detenuto $52.7B
Nuove posizioni 248
Posizioni chiuse 85
Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
248 (+126 vs trimestre precedente) 85 (-76 vs trimestre precedente) 325 (+68 vs trimestre precedente) 288 (-56 vs trimestre precedente) +3.9M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
Dodge & Cox $4.345.737.744 10.940.380 8,25% Azioni
BlackRock, Inc. $4.138.159.785 10.417.803 7,85% Azioni
VANGUARD GROUP INC $3.652.890.202 14.261.860 6,93% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $3.115.642.737 7.843.620 5,91% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $2.311.405.702 5.818.956 4,39% Azioni
STATE STREET CORP $2.172.441.313 5.457.072 4,12% Azioni
PZENA INVESTMENT MANAGEMENT LLC $1.749.013.682 4.403.136 3,32% Azioni
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $1.664.784.292 3.578.245 3,16% Azioni
EAGLE CAPITAL MANAGEMENT LLC $1.528.010.749 3.846.762 2,90% Azioni
Sessa Capital IM, L.P. $1.480.732.883 3.727.740 2,81% Azioni
GEODE CAPITAL MANAGEMENT, LLC $1.337.386.742 3.369.757 2,54% Azioni
JPMORGAN CHASE & CO $1.257.951.102 3.234.637 2,39% Azioni
FMR LLC $1.157.405.236 2.913.763 2,20% Azioni
Capital International Investors $950.462.637 2.392.826 1,80% Azioni
GOLDMAN SACHS GROUP INC $913.562.254 2.299.889 1,73% Azioni
NAYA CAPITAL MANAGEMENT UK LTD $728.407.339 1.833.763 1,38% Azioni
NORGES BANK $694.505.009 1.748.414 1,32% Azioni
Invesco Ltd. $587.403.999 1.478.788 1,11% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544.521.489 1.370.831 1,03% Azioni
MORGAN STANLEY $535.876.914 1.349.066 1,02% Azioni
DIMENSIONAL FUND ADVISORS LP $445.839.059 1.122.669 0,85% Azioni
Capital Research Global Investors $443.462.035 1.116.990 0,84% Azioni
NORTHERN TRUST CORP $442.978.948 1.115.198 0,84% Azioni
Slate Path Capital LP $428.969.795 1.079.930 0,81% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $423.436.520 1.066.000 0,80% Opzione Put
Capital World Investors $406.119.738 1.022.425 0,77% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $399.841.652 1.006.600 0,76% Opzione Call
Newport Trust Company, LLC $384.768.345 968.653 0,73% Azioni
CITADEL ADVISORS LLC $363.376.856 914.800 0,69% Opzione Call
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348.908.912 878.377 0,66% Azioni
Legal & General Group Plc $329.760.125 830.170 0,63% Azioni
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314.921.577 792.814 0,60% Azioni
CITADEL ADVISORS LLC $310.904.094 782.700 0,59% Opzione Put
Allianz Asset Management GmbH $307.098.329 773.119 0,58% Azioni
WELLINGTON MANAGEMENT GROUP LLP $304.014.312 765.355 0,58% Azioni
BANK OF AMERICA CORP /DE/ $279.490.113 703.615 0,53% Azioni
VANGUARD FIDUCIARY TRUST CO $267.791.027 674.163 0,51% Azioni
Maple Rock Capital Partners Inc. $249.553.862 628.251 0,47% Azioni
Diamond Hill Capital Management, LLC (Investment Advisor) $245.555.446 618.185 0,47% Azioni
Bank of New York Mellon Corp $238.144.113 599.527 0,45% Azioni
GOLDMAN SACHS GROUP INC $232.333.978 584.900 0,44% Opzione Call
MARSHALL WACE, LLP $216.873.381 545.978 0,41% Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $189.649.820 1.093.776 0,36% Azioni
CITADEL ADVISORS LLC $178.360.519 449.022 0,34% Azioni
High Ground Investment Management LLP $177.941.848 447.968 0,34% Azioni
1832 Asset Management L.P. $176.401.430 444.090 0,33% Azioni
BCV Asset Management Inc. $173.695.656 445.719 0,33% Azioni
Nuveen, LLC $167.646.743 422.051 0,32% Azioni
Holocene Advisors, LP $165.040.541 415.489 0,31% Azioni
DEUTSCHE BANK AG\ $163.345.207 411.221 0,31% Azioni

Mostra tutti i 1.038 proprietari istituzionali →

Attivisti e proprietari del 5%+ 1 partecipazione

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
David A. Jones ×2 depositi 12 Novembre 2003 · Deposito iniziale · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 79 insider · 48 dirigenti · 29 direttori

19
Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
James A. Rechtin President & CEO 01 Maggio 2026 A 63.938 0 0 $0
Bruce D Broussard Chief Executive Officer 21 Febbraio 2024 A 110.130 0 0 $0
Celeste Mellet Chief Financial Officer 01 Maggio 2026 A 39.637 0 0 $0
Susan M Diamond Chief Financial Officer 31 Dicembre 2024 J 20.165 0 0 $0
Brian A Kane Chief Financial Officer 22 Febbraio 2021 A 24.342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer 09 Maggio 2014 G 14.916 0 0 $0
Aaron Martin President, Medicare Advantage 01 Maggio 2026 A 25.237 0 0 $0
David Dintenfass President, Enterprise Growth 01 Maggio 2026 A 25.407 0 0 $0
Sanjay K Shetty President, CenterWell 01 Maggio 2026 A 22.088 1 0 $150.012
George Renaudin II President, Insurance 31 Marzo 2026 J 16.075 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions 24 Febbraio 2023 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail 15 Dicembre 2022 M 3.983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery 15 Dicembre 2017 M 222 0 0 $0
Thomas J Liston President - Retail Segment 18 Febbraio 2014 A 105.443 0 0 $0
James E Murray EVP & COO 31 Marzo 2017 J 34.668 0 0 $0
Shantanu Nundy Chief Medical Officer 01 Settembre 2026 A 2.549 0 0 $0
Japan Mehta Chief Information Officer 01 Maggio 2026 A 17.176 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer 01 Maggio 2026 A 20.026 0 0 $0
Joseph C Ventura Chief Legal Officer 01 Maggio 2026 A 27.405 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. 24 Febbraio 2026 F 7.484 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer 24 Febbraio 2025 A 16.717 0 0 $0
Timothy S. Huval Chief Administrative Officer 31 Dicembre 2024 G 7.111 0 0 $0
Samir Deshpande Chief Information Officer 15 Dicembre 2024 M 14.015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer 21 Febbraio 2024 A 11.723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. 24 Febbraio 2023 F 3.687 0 0 $0
William H Shrank Chief Medical Officer 01 Maggio 2022 M 4.294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont 22 Marzo 2022 J 5.723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. 25 Febbraio 2022 F 6.014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. 16 Marzo 2021 G 8.168 0 0 $0
Elizabeth D Bierbower Strategic Advisor 18 Dicembre 2019 M 18.092 0 0 $0
Brian P. Leclaire Strategic Advisor 15 Dicembre 2019 M 6.339 0 0 $0
Jody L Bilney Chief Consumer Officer 25 Febbraio 2019 A 9.774 0 0 $0
Roy A Beveridge, Chief Medical Officer 19 Febbraio 2019 M 10.791 0 0 $0
Todoroff M Christopher Chief Legal Officer 15 Dicembre 2018 M 11.136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer 15 Dicembre 2018 M 6.476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer 17 Marzo 2017 M 4.361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin 18 Febbraio 2014 A 1.101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services 18 Febbraio 2014 A 15.946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer 24 Giugno 2013 M 19.347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off 24 Dicembre 2012 G 2.287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of 28 Aprile 2012 F 11.946 0 0 $0
GOODMAN BRUCE J Sr. VP 23 Febbraio 2012 A 23.280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. 04 Febbraio 2009 I 0 0 0 $0
Arthur P Hipwell Senior Vice President 27 Marzo 2008 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel 25 Febbraio 2008 F 13.836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer 31 Dicembre 2007 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary 23 Febbraio 2007 M 57.548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm 06 Gennaio 2005 M 0 0 0 $0
Kurt J Hilzinger Direttore 30 Settembre 2026 A 19.448 0 0 $0
Paul John Smith Direttore 01 Agosto 2026 A 544 0 0 $0
Robert Stuart Field Direttore 01 Maggio 2026 A 852 0 0 $0
Jorge S. Mesquita Direttore 02 Gennaio 2026 A 4.127 0 0 $0
Frank A Damelio Direttore 02 Gennaio 2026 A 20.634 0 0 $0
Raquel C. Bono Direttore 31 Dicembre 2025 A 397 0 0 $0
Wayne A.I. Frederick Direttore 31 Dicembre 2025 A 440 0 0 $0
Marcy S Klevorn Direttore 31 Dicembre 2025 A 436 0 0 $0
John W Garratt Direttore 31 Dicembre 2025 A 1.685 0 0 $0
David T Feinberg Direttore 31 Dicembre 2025 A 1.207 0 0 $0
Karen Katz Direttore 31 Dicembre 2025 A 590 0 0 $0
Brad D Smith Direttore 31 Dicembre 2024 A 1.169 0 0 $0
William J. Mcdonald Direttore 02 Gennaio 2024 A 2.276 0 0 $0
JONES DAVID A JR/KY Direttore 28 Febbraio 2023 G 32.440 0 0 $0
OBRIEN JAMES J /KY Direttore 03 Gennaio 2023 A 1.794 0 0 $0
Marissa T Peterson Direttore 03 Gennaio 2022 A 2.044 0 0 $0
Frank Bisignano Direttore 04 Gennaio 2021 A 2.727 0 0 $0
Webster Roy Dunbar Direttore 31 Dicembre 2019 A 2.880 0 0 $0
Karen B Desalvo Direttore 02 Gennaio 2019 A 634 0 0 $0
David Nash Direttore 02 Gennaio 2019 A 112 0 0 $0
William Mitchell Direttore 31 Dicembre 2018 A 688 0 0 $0
Michael B Mccallister Direttore 31 Dicembre 2013 M 113.885 0 0 $0
Ann W Reynolds Direttore 15 Maggio 2011 M 39.727 0 0 $0
James O Robbins Direttore 03 Gennaio 2007 A · 0 0 $0
HALL JOHN R /KY Direttore 03 Gennaio 2006 A 22.423 0 0 $0
JONES DAVID A SR/KY Direttore 05 Aprile 2005 G 4.777.524 0 0 $0
Michael E Gellert Direttore 03 Gennaio 2005 A 60.237 0 0 $0
Irwin Lerner Direttore 02 Gennaio 2004 A 30.637 0 0 $0
Frederick John Crawford · 01 Agosto 2026 A 544 0 0 $0
Gordon Smith · 31 Dicembre 2025 A 765 0 0 $0
James H Bloem · 07 Novembre 2013 M 30.326 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 143 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
IHF · iShares Trust 4,63% 151.582 SH 11 Settembre 2026 Giornaliero
FMTM · EA Series Trust 3,07% 21.303 NS 31 Luglio 2026 N-PORT
TGLB · T. Rowe Price Exchange-Traded Funds… 2,57% 1.854 NS 31 Luglio 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 2,35% 103.450 SH 02 Ottobre 2026 Giornaliero
SRHQ · Elevation Series Trust 2,31% 13.473 NS 31 Luglio 2026 N-PORT
EPMV · Harbor ETF Trust 1,75% 225 NS 31 Luglio 2026 N-PORT
CVAR · ETF Opportunities Trust 1,71% 2.014 NS 31 Luglio 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,57% 35.951 SH 02 Ottobre 2026 Giornaliero
NUMV · Nushares ETF Trust 1,39% 16.939 NS 31 Luglio 2026 N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 1,16% 290 NS 31 Luglio 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0,88% 32.276 NS 31 Luglio 2026 N-PORT
VOE · VANGUARD INDEX FUNDS 0,82% 771.237 SH 19 Agosto 2026 Giornaliero
IYH · iShares Trust 0,78% 70.303 SH 11 Settembre 2026 Giornaliero
JOET · Virtus ETF Trust II 0,74% 4.940 NS 31 Luglio 2026 N-PORT
PALC · Pacer Funds Trust 0,74% 4.248 NS 31 Luglio 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0,71% 181.374 SH 02 Ottobre 2026 Giornaliero
VHT · VANGUARD WORLD FUND 0,70% 360.880 SH 19 Agosto 2026 Giornaliero
PDP · Invesco Exchange-Traded Fund Trust 0,70% 27.208 SH 02 Ottobre 2026 Giornaliero
FHLC · FIDELITY COVINGTON TRUST 0,63% 57.108 NS 31 Luglio 2026 N-PORT
IXJ · iShares Trust 0,61% 63.215 SH 11 Settembre 2026 Giornaliero
CURE · Direxion Shares ETF Trust 0,50% 2.362 NS 31 Luglio 2026 N-PORT
IWS · iShares Trust 0,47% 179.478 SH 11 Settembre 2026 Giornaliero
VO · VANGUARD INDEX FUNDS 0,46% 2.601.869 SH 19 Agosto 2026 Giornaliero
IMCV · iShares Trust 0,40% 11.586 SH 11 Settembre 2026 Giornaliero
MTUM · iShares Trust 0,37% 227.558 SH 11 Settembre 2026 Giornaliero
IWR · iShares Trust 0,35% 492.212 SH 11 Settembre 2026 Giornaliero
PRF · Invesco Exchange-Traded Fund Trust 0,34% 88.063 SH 02 Ottobre 2026 Giornaliero
IMCB · iShares Trust 0,34% 14.123 SH 11 Settembre 2026 Giornaliero
VRP · Invesco Exchange-Traded Fund Trust … 0,33% 10.420.000 02 Ottobre 2026 Giornaliero
FFLC · FIDELITY COVINGTON TRUST 0,32% 10.722 NS 31 Luglio 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,32% 8.116 SH 02 Ottobre 2026 Giornaliero
IMCG · iShares Trust 0,27% 27.157 SH 11 Settembre 2026 Giornaliero
XOEF · iShares Trust 0,27% 151 SH 11 Settembre 2026 Giornaliero
VLUE · iShares Trust 0,26% 62.879 SH 11 Settembre 2026 Giornaliero
PFIG · Invesco Exchange-Traded Fund Trust … 0,25% 320.000 02 Ottobre 2026 Giornaliero
SIZE · iShares Trust 0,24% 2.599 SH 11 Settembre 2026 Giornaliero
BSCS · Invesco Exchange-Traded Self-Indexe… 0,23% 8.027.000 02 Ottobre 2026 Giornaliero
ROUS · Lattice Strategies Trust 0,23% 4.462 NS 31 Luglio 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,22% 9.983.000 02 Ottobre 2026 Giornaliero
EUSA · iShares, Inc. 0,22% 10.324 SH 11 Settembre 2026 Giornaliero
HELO · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 26.395 NS 31 Luglio 2026 N-PORT
CATH · Global X Funds 0,21% 7.419 NS 31 Luglio 2026 N-PORT
VYM · VANGUARD WHITEHALL FUNDS 0,20% 479.438 SH 19 Agosto 2026 Giornaliero
RSP · Invesco Exchange-Traded Fund Trust 0,19% 487.833 SH 02 Ottobre 2026 Giornaliero
EVUS · iShares Trust 0,19% 1.842 SH 11 Settembre 2026 Giornaliero
USXF · iShares Trust 0,19% 7.125 SH 11 Settembre 2026 Giornaliero
ESMV · iShares Trust 0,19% 37 SH 11 Settembre 2026 Giornaliero
SUSA · iShares Trust 0,19% 19.078 SH 11 Settembre 2026 Giornaliero
ACVF · ETF Opportunities Trust 0,19% 790 NS 31 Luglio 2026 N-PORT
VTV · VANGUARD INDEX FUNDS 0,18% 1.140.642 SH 19 Agosto 2026 Giornaliero
DFLV · Dimensional ETF Trust 0,18% 32.943 NS 31 Luglio 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,17% 3.921 NS 31 Luglio 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,17% 3.648 SH 19 Agosto 2026 Giornaliero
DFSU · Dimensional ETF Trust 0,17% 10.472 NS 31 Luglio 2026 N-PORT
IVE · iShares Trust 0,16% 200.080 SH 11 Settembre 2026 Giornaliero
VOOV · VANGUARD ADMIRAL FUNDS 0,16% 27.648 SH 19 Agosto 2026 Giornaliero
IUSV · iShares Trust 0,15% 104.740 SH 11 Settembre 2026 Giornaliero
VEGN · ETF Series Solutions 0,15% 709 NS 31 Luglio 2026 N-PORT
DFUV · Dimensional ETF Trust 0,14% 60.086 NS 31 Luglio 2026 N-PORT
SUSL · iShares Trust 0,14% 4.238 SH 11 Settembre 2026 Giornaliero
FYEE · Fidelity Greenwood Street Trust 0,14% 839 NS 31 Luglio 2026 N-PORT
DSI · iShares Trust 0,14% 18.418 SH 11 Settembre 2026 Giornaliero
IQSU · New York Life Investments ETF Trust 0,14% 1.230 NS 31 Luglio 2026 N-PORT
CHRI · Global X Funds 0,13% 29 NS 31 Luglio 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 0,13% 72.504 SH 19 Agosto 2026 Giornaliero
IWD · iShares Trust 0,13% 267.199 SH 11 Settembre 2026 Giornaliero
BSCT · Invesco Exchange-Traded Self-Indexe… 0,12% 3.809.000 02 Ottobre 2026 Giornaliero
NULV · Nushares ETF Trust 0,11% 6.797 NS 31 Luglio 2026 N-PORT
ESGU · iShares Trust 0,11% 47.962 SH 11 Settembre 2026 Giornaliero
DGRO · iShares Trust 0,10% 111.232 SH 11 Settembre 2026 Giornaliero
EGLE · Global X Funds 0,10% 6 NS 31 Luglio 2026 N-PORT
GLBL · Pacer Funds Trust 0,10% 3 NS 31 Luglio 2026 N-PORT
LQAI · Exchange Listed Funds Trust 0,10% 6 NS 31 Luglio 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 1.886 SH 02 Ottobre 2026 Giornaliero
TOPC · iShares Trust 0,09% 72 SH 11 Settembre 2026 Giornaliero
ILCV · iShares Trust 0,08% 2.783 SH 11 Settembre 2026 Giornaliero
XVV · iShares Trust 0,08% 1.375 SH 11 Settembre 2026 Giornaliero
VV · VANGUARD INDEX FUNDS 0,08% 140.219 SH 19 Agosto 2026 Giornaliero
ESGV · VANGUARD WORLD FUND 0,08% 27.152 SH 19 Agosto 2026 Giornaliero
QVML · Invesco Exchange-Traded Fund Trust … 0,08% 3.447 SH 02 Ottobre 2026 Giornaliero
DFAC · Dimensional ETF Trust 0,08% 100.648 NS 31 Luglio 2026 N-PORT
XTR · Global X Funds 0,08% 10 NS 31 Luglio 2026 N-PORT
IVV · iShares Trust 0,07% 1.513.176 SH 11 Settembre 2026 Giornaliero
ILCB · iShares Trust 0,07% 2.328 SH 11 Settembre 2026 Giornaliero
XCLR · Global X Funds 0,07% 7 NS 31 Luglio 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,07% 3.119.147 SH 19 Agosto 2026 Giornaliero
VTI · VANGUARD INDEX FUNDS 0,07% 3.812.375 SH 19 Agosto 2026 Giornaliero
VONE · VANGUARD SCOTTSDALE FUNDS 0,07% 19.809 SH 19 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,07% 10.113 SH 19 Agosto 2026 Giornaliero
PBP · Invesco Exchange-Traded Fund Trust 0,07% 715 SH 02 Ottobre 2026 Giornaliero
PBUS · Invesco Exchange-Traded Fund Trust … 0,07% 20.848 SH 02 Ottobre 2026 Giornaliero
IYY · iShares Trust 0,07% 5.172 SH 11 Settembre 2026 Giornaliero
IWB · iShares Trust 0,07% 82.919 SH 11 Settembre 2026 Giornaliero
XYLD · Global X Funds 0,07% 6.091 NS 31 Luglio 2026 N-PORT
PTLC · Pacer Funds Trust 0,07% 6.112 NS 31 Luglio 2026 N-PORT
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 16.615 NS 31 Luglio 2026 N-PORT
USCL · iShares Trust 0,07% 4.768 SH 11 Settembre 2026 Giornaliero
VOTE · TCW ETF Trust 0,07% 2.035 NS 31 Luglio 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0,07% 10.127 NS 31 Luglio 2026 N-PORT
XRMI · Global X Funds 0,07% 92 NS 31 Luglio 2026 N-PORT
IWV · iShares Trust 0,07% 33.101 SH 11 Settembre 2026 Giornaliero
ITOT · iShares Trust 0,07% 156.223 SH 11 Settembre 2026 Giornaliero
LRGF · iShares Trust 0,06% 5.842 SH 11 Settembre 2026 Giornaliero
DXUV · Dimensional ETF Trust 0,06% 959 NS 31 Luglio 2026 N-PORT
DFUS · Dimensional ETF Trust 0,06% 36.333 NS 31 Luglio 2026 N-PORT
XYLG · Global X Funds 0,06% 111 NS 31 Luglio 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,06% 453 NS 31 Luglio 2026 N-PORT
ILCG · iShares Trust 0,06% 4.804 SH 11 Settembre 2026 Giornaliero
QDPL · Pacer Funds Trust 0,06% 2.883 NS 31 Luglio 2026 N-PORT
TOV · EA Series Trust 0,06% 454 NS 31 Luglio 2026 N-PORT
TILT · FlexShares Trust 0,06% 3.564 NS 31 Luglio 2026 N-PORT
DFAU · Dimensional ETF Trust 0,06% 20.053 NS 31 Luglio 2026 N-PORT
PHDG · Invesco Actively Managed Exchange-T… 0,06% 95 SH 02 Ottobre 2026 Giornaliero
VOXP · Advisors Series Trust 0,06% 9 NS 31 Luglio 2026 N-PORT
TOK · iShares Trust 0,06% 333 SH 11 Settembre 2026 Giornaliero
HCMT · Direxion Shares ETF Trust 0,05% 835 NS 31 Luglio 2026 N-PORT
DCOR · Dimensional ETF Trust 0,05% 4.948 NS 31 Luglio 2026 N-PORT
URTH · iShares, Inc. 0,05% 10.772 SH 11 Settembre 2026 Giornaliero
SPXL · Direxion Shares ETF Trust 0,05% 9.382 NS 31 Luglio 2026 N-PORT
ACWI · iShares Trust 0,05% 38.539 SH 11 Settembre 2026 Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,04% 196.805 SH 19 Agosto 2026 Giornaliero
OMFL · Invesco Exchange-Traded Self-Indexe… 0,04% 4.718 SH 02 Ottobre 2026 Giornaliero
NEAR · iShares U.S. ETF Trust 0,03% 1.504.000 SH 11 Settembre 2026 Giornaliero
GLOF · iShares Trust 0,02% 106 SH 11 Settembre 2026 Giornaliero
DYNF · BlackRock ETF Trust 0,01% 14.919 SH 11 Settembre 2026 Giornaliero
CRBN · iShares Trust 0,01% 383 SH 11 Settembre 2026 Giornaliero
VXUS · VANGUARD STAR FUNDS 0,00% 4.397.881 SH 19 Agosto 2026 Giornaliero
VPL · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 401.850 SH 19 Agosto 2026 Giornaliero
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 932.492 SH 19 Agosto 2026 Giornaliero
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 2.391.019 SH 19 Agosto 2026 Giornaliero
VSGX · VANGUARD WORLD FUND 0,00% 54.062 SH 19 Agosto 2026 Giornaliero
BIV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BLV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BSV · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
BND · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
VUSB · VANGUARD BOND INDEX FUNDS · · 15 Luglio 2026 Giornaliero
VPLS · VANGUARD MALVERN FUNDS · · 15 Luglio 2026 Giornaliero
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 Luglio 2026 Giornaliero
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 Luglio 2026 Giornaliero
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 Luglio 2026 Giornaliero
VCEB · VANGUARD WORLD FUND · · 30 Luglio 2026 Giornaliero

HUM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21
rating · 33 analisti COMPRA
Target mediano $420.00 +8,1%
8 24,2% Acquisto forte
8 24,2% Compra
16 48,5% Mantieni
1 3,0% Vendi
0 0,0% Vendita forte

Target Price a 12 Mesi

23 analisti · 2026-09-30

Target medio $423.74 +9,1%

Ora Prezzo attuale $388.36
Basso$280.00 Media$423.74 Alto$515.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
HUM $50.90B 26.0 10.1% 0.92% 7.0% ·
UNH $299.08B 25.0 11.8% 2.7% 12.0% ·
ELV $77.37B 13.9 12.5% 2.8% 13.3% ·
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9% ·
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
CLOV · -5.1 40.3% -4.5% -26.2% ·
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%
ALHC $4.03B · 46.1% -0.02% -0.52% ·

Ultime notizie Notizie recenti che menzionano questa società

23

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Fonte: SEC 10-Q depositato Lug 29, 2026